| Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation (NCT00180089) | Technische Universität Dresden | 2004-01-01 |
| Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients (NCT00709813) | Oslo University Hospital | 2003-12-01 |
| Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes (NCT00072475) | Alliance for Clinical Trials in Oncology | 2003-12-01 |
| Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (NCT00081133) | Memorial Sloan Kettering Cancer Center | 2003-12-01 |
| Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy (NCT00070174) | Children's Oncology Group | 2003-12-01 |
| Zinc Supplements in Lowering Cadmium Levels in Smokers (NCT00376987) | Wake Forest University Health Sciences | 2003-12-01 |
| Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer (NCT00255684) | University of Rochester | 2003-12-01 |
| BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate (NCT00064233) | Jonsson Comprehensive Cancer Center | 2003-11-01 |
| Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome (NCT00077116) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-11-01 |
| Busulfan and Fludarabine in Patients With AML and MDS (NCT00502905) | M.D. Anderson Cancer Center | 2003-10-01 |
| Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant (NCT00534118) | Roswell Park Cancer Institute | 2003-10-01 |
| BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia (NCT00074048) | MedImmune LLC | 2003-10-01 |
| PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia (NCT00362544) | Gilead Sciences | 2003-10-01 |
| Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases (NCT00084695) | Milton S. Hershey Medical Center | 2003-09-01 |
| CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant (NCT00369291) | Masonic Cancer Center, University of Minnesota | 2003-09-01 |
| Genetic Study of Chronic Lymphocytic Leukemia Families (NCT00503256) | M.D. Anderson Cancer Center | 2003-09-01 |
| Oral Valganciclovir Versus Valacyclovir (NCT00562770) | M.D. Anderson Cancer Center | 2003-09-01 |
| Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer (NCT00248430) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer (NCT00070382) | Jonsson Comprehensive Cancer Center | 2003-08-01 |
| Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease (NCT00118326) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients (NCT00386373) | M.D. Anderson Cancer Center | 2003-08-01 |
| Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets (NCT00074763) | M.D. Anderson Cancer Center | 2003-07-01 |
| Cholecalciferol in Treating Patients With Myelodysplastic Syndrome (NCT00068276) | Wake Forest University Health Sciences | 2003-07-01 |
| VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia (NCT00505700) | Massachusetts General Hospital | 2003-07-01 |
| Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia (NCT00281918) | Hoffmann-La Roche | 2003-07-01 |
| Molecular Epidemiology of Acute Myelogenous Leukemia (NCT00502983) | M.D. Anderson Cancer Center | 2003-06-23 |
| Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy (NCT00066599) | National Cancer Institute (NCI) | 2003-06-01 |
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia (NCT00066326) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| Epoetin Alfa in Treating Anemia in Patients With Solid Tumors (NCT00058331) | Alliance for Clinical Trials in Oncology | 2003-06-01 |
| Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies (NCT00068523) | Case Comprehensive Cancer Center | 2003-06-01 |
| VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies (NCT00070538) | Vion Pharmaceuticals | 2003-06-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer (NCT00064285) | Virginia Commonwealth University | 2003-06-01 |
| Phase I Study of Sequential Cord Blood Transplants (NCT00299767) | Massachusetts General Hospital | 2003-05-01 |
| Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML (NCT00416884) | OHSU Knight Cancer Institute | 2003-05-01 |
| Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment (NCT00072579) | Wake Forest University Health Sciences | 2003-05-01 |
| Paricalcitol in Treating Patients With Myelodysplastic Syndrome (NCT00064376) | Cedars-Sinai Medical Center | 2003-05-01 |
| Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00062140) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Study of @neWorld: A Virtual Community for Children With Cancer (NCT00070421) | Leap of Faith Technologies | 2003-04-01 |
| Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma (NCT00631579) | Sanofi | 2003-04-01 |
| S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia (NCT00053014) | SWOG Cancer Research Network | 2003-04-01 |
| Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00112567) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00062296) | Fox Chase Cancer Center | 2003-03-01 |
| Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy (NCT01099202) | M.D. Anderson Cancer Center | 2003-03-01 |
| A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies (NCT00621244) | Novartis Pharmaceuticals | 2003-03-01 |
| 3-AP and Cytarabine in Treating Patients With Hematologic Cancer (NCT00064090) | Vion Pharmaceuticals | 2003-03-01 |
| Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies (NCT00185640) | Stanford University | 2003-03-01 |
| Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate (NCT00156299) | Rutgers, The State University of New Jersey | 2003-03-01 |
| Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (NCT00499889) | M.D. Anderson Cancer Center | 2003-02-01 |
| Exercise Program for Adolescents and Young Adults With Cancer (NCT00502749) | M.D. Anderson Cancer Center | 2003-02-01 |
| Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation (NCT00057005) | Baylor College of Medicine | 2003-02-01 |
| Natural History Study of Patients With Chronic Myelogenous Leukemia (NCT00429910) | Dana-Farber Cancer Institute | 2003-02-01 |
| Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders (NCT00055653) | Roswell Park Cancer Institute | 2003-01-01 |
| Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF (NCT00952237) | Dartmouth-Hitchcock Medical Center | 2003-01-01 |
| Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma (NCT00068302) | Children's Hospital of Philadelphia | 2003-01-01 |
| Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia (NCT00343369) | Universitätsklinikum Hamburg-Eppendorf | 2003-01-01 |
| Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer (NCT00301860) | University of California, San Francisco | 2003-01-01 |
| C-Reactive Protein as a Predictor of Stem Cell Transplant Complications (NCT00179868) | Ann & Robert H Lurie Children's Hospital of Chicago | 2003-01-01 |
| Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (NCT00078520) | Baylor College of Medicine | 2003-01-01 |
| Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer (NCT00627666) | Asan Medical Center | 2003-01-01 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia (NCT00049517) | Eastern Cooperative Oncology Group | 2002-12-19 |
| Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00265837) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-12-01 |
| Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia (NCT00056069) | Children's Oncology Group | 2002-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer (NCT00053196) | Alliance for Clinical Trials in Oncology | 2002-12-01 |
| Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies (NCT00113646) | Massachusetts General Hospital | 2002-11-01 |
| Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia (NCT00764907) | University Hospital, Motol | 2002-11-01 |
| Unrelated Donor Transplant for Malignant and Non-Malignant Disorders (NCT01050439) | Columbia University | 2002-11-01 |
| Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia (NCT00022126) | Children's Oncology Group | 2002-11-01 |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia (NCT00671658) | M.D. Anderson Cancer Center | 2002-11-01 |
| Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00058396) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies (NCT00048737) | M.D. Anderson Cancer Center | 2002-10-01 |
| Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00052416) | Beth Israel Deaconess Medical Center | 2002-10-01 |
| Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders (NCT00052572) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00304018) | University of California, San Francisco | 2002-10-01 |
| Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder (NCT00054340) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia (NCT00046930) | Eastern Cooperative Oncology Group | 2002-09-17 |
| Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT00052832) | University of Wisconsin, Madison | 2002-09-01 |
| Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine (NCT00274976) | German CLL Study Group | 2002-09-01 |
| Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS (NCT00053287) | Case Comprehensive Cancer Center | 2002-09-01 |
| Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00052299) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-09-01 |
| Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia (NCT00049075) | NCIC Clinical Trials Group | 2002-08-08 |
| Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia (NCT00082940) | Wake Forest University Health Sciences | 2002-08-01 |
| Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia (NCT00021242) | Children's Oncology Group | 2002-08-01 |
| Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00028899) | Children's Oncology Group | 2002-07-01 |
| Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer (NCT00255710) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-07-01 |
| Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma (NCT00082303) | National Center for Complementary and Integrative Health (NCCIH) | 2002-07-01 |
| Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma (NCT00045513) | University Health Network, Toronto | 2002-06-01 |
| Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia (NCT00053157) | Roswell Park Cancer Institute | 2002-06-01 |
| Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers (NCT00899795) | OHSU Knight Cancer Institute | 2002-06-01 |
| Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (NCT00055874) | Heidelberg University | 2002-06-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma (NCT00049413) | Hoag Memorial Hospital Presbyterian | 2002-06-01 |
| Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL (NCT00072007) | Swiss Cancer Institute | 2002-06-01 |
| FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma (NCT00042822) | Memorial Sloan Kettering Cancer Center | 2002-05-01 |
| Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen (NCT00774280) | Cooperative Study Group A for Hematology | 2002-05-01 |
| Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia (NCT00039130) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| Dysregulated Tyrosine Kinase Signaling in Leukemia (NCT00277056) | University of New Mexico | 2002-05-01 |
| Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) (NCT00185523) | Stanford University | 2002-05-01 |
| Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia (NCT00096018) | Roswell Park Cancer Institute | 2002-05-01 |
| Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia (NCT00054236) | Case Comprehensive Cancer Center | 2002-05-01 |